News

June 19, 2020June 19, 2020

MEFV Gene Mutation May Be Risk Factor for sJIA, Study Suggests

News

A specific mutation in the MEFV gene, which has been linked to inflammation, may be a risk factor for developing systemic juvenile idiopathic arthritis (sJIA), a study in China ... Read more

June 12, 2020June 12, 2020

Enbrel Biosimilar Nepexto Approved in Europe for JIA, Other Inflammatory Disorders

News

The European Commission has approved Nepexto, a biosimilar of Enbrel (etanercept), for the treatment of juvenile idiopathic arthritis and other inflammatory disorders. Nepexto is expected to be available to patients in the European ... Read more

June 5, 2020June 5, 2020

Teens in Netherlands Can Disregard Disease in Planning for Future, Survey Finds

News

Teenagers with juvenile idiopathic arthritis (JIA) in the Netherlands show a desire for “normalcy” and willingness not to consider their disease in career plans, voicing in a survey hopes ... Read more

May 29, 2020May 29, 2020

Nearly One-fifth of Infections Opportunistic in JIA Children on Immunosuppressants, Study Reports

News

Close to one-fifth of infections in children with juvenile idiopathic arthritis (JIA) on immunosuppressants are caused by opportunistic pathogens — such as microorganisms that take advantage of weakened immune ... Read more

May 22, 2020May 22, 2020

Short Film on Woman with Juvenile Arthritis Highlights Awareness Month

News

A new short film called “Joint Effort” traces the journey of Zoe Zeerip, a Michigan woman who was diagnosed with juvenile idiopathic arthritis (JIA) at age 13. “At such ... Read more

May 21, 2020May 21, 2020

Video Games Connect Chronically Ill Children Isolated at Home, Hospital

cystic fibrosis, News, syndicated

Dara Riva always had a rule that her 10-year-old son could play video games only once a week. But then the COVID-19 pandemic struck, and her perspective changed. Riva’s ... Read more

May 15, 2020May 15, 2020

Janssen Seeks FDA Approval for Simponi Aria in JIA Subtypes

News

Janssen has submitted two new applications to the U.S. Food and Drug Administration (FDA) seeking approval for Simponi Aria (golimumab), in combination with methotrexate, for the treatment of polyarticular juvenile ... Read more

May 8, 2020May 8, 2020

Mobile App Helps Young Arthritis Patients Track Symptoms, Connect with Peers

News

Adolescents and young adults with juvenile arthritis now can rate their daily symptoms in a matter of seconds, track their disease over a period of time, and connect with others ... Read more

April 27, 2020April 27, 2020

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

News, syndicated

While there are few silver linings to the cloud created by COVID-19, the pandemic that has killed tens of thousands, hobbled economies worldwide and drove millions to quarantine in ... Read more

April 24, 2020April 24, 2020

Early Treatment Tied to Inactive Disease Within 1 Year, Canadian Registry Shows

News

Early treatment for juvenile idiopathic arthritis (JIA) is likely the reason for most children with JIA taking part in a Canadian patient registry having inactive disease within one year of diagnosis, ... Read more

Pin It on Pinterest